vs

Side-by-side financial comparison of NU SKIN ENTERPRISES, INC. (NUS) and Tempus AI, Inc. (TEM). Click either name above to swap in a different company.

Tempus AI, Inc. is the larger business by last-quarter revenue ($367.2M vs $320.6M, roughly 1.1× NU SKIN ENTERPRISES, INC.). NU SKIN ENTERPRISES, INC. runs the higher net margin — 0.6% vs -14.8%, a 15.3% gap on every dollar of revenue. On growth, Tempus AI, Inc. posted the faster year-over-year revenue change (83.0% vs -12.0%). Over the past eight quarters, Tempus AI, Inc.'s revenue compounded faster (58.7% CAGR vs -14.5%).

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."

NUS vs TEM — Head-to-Head

Bigger by revenue
TEM
TEM
1.1× larger
TEM
$367.2M
$320.6M
NUS
Growing faster (revenue YoY)
TEM
TEM
+95.0% gap
TEM
83.0%
-12.0%
NUS
Higher net margin
NUS
NUS
15.3% more per $
NUS
0.6%
-14.8%
TEM
Faster 2-yr revenue CAGR
TEM
TEM
Annualised
TEM
58.7%
-14.5%
NUS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NUS
NUS
TEM
TEM
Revenue
$320.6M
$367.2M
Net Profit
$1.8M
$-54.2M
Gross Margin
66.9%
Operating Margin
34.4%
-16.7%
Net Margin
0.6%
-14.8%
Revenue YoY
-12.0%
83.0%
Net Profit YoY
-316.2%
EPS (diluted)
$0.04
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUS
NUS
TEM
TEM
Q1 26
$320.6M
Q4 25
$370.3M
$367.2M
Q3 25
$364.2M
$334.2M
Q2 25
$386.1M
$314.6M
Q1 25
$364.5M
$255.7M
Q4 24
$445.6M
$200.7M
Q3 24
$430.1M
$180.9M
Q2 24
$439.1M
$166.0M
Net Profit
NUS
NUS
TEM
TEM
Q1 26
$1.8M
Q4 25
$14.5M
$-54.2M
Q3 25
$17.1M
$-80.0M
Q2 25
$21.1M
$-42.8M
Q1 25
$107.5M
$-68.0M
Q4 24
$-36.1M
$-13.0M
Q3 24
$8.3M
$-75.8M
Q2 24
$-118.3M
$-552.2M
Gross Margin
NUS
NUS
TEM
TEM
Q1 26
66.9%
Q4 25
70.7%
Q3 25
70.5%
Q2 25
68.8%
Q1 25
67.8%
Q4 24
62.7%
Q3 24
70.1%
Q2 24
70.0%
Operating Margin
NUS
NUS
TEM
TEM
Q1 26
34.4%
Q4 25
6.3%
-16.7%
Q3 25
5.9%
-18.3%
Q2 25
8.0%
-19.6%
Q1 25
-2.7%
-26.9%
Q4 24
-11.9%
-25.3%
Q3 24
4.2%
-29.6%
Q2 24
-28.6%
-321.4%
Net Margin
NUS
NUS
TEM
TEM
Q1 26
0.6%
Q4 25
3.9%
-14.8%
Q3 25
4.7%
-23.9%
Q2 25
5.5%
-13.6%
Q1 25
29.5%
-26.6%
Q4 24
-8.1%
-6.5%
Q3 24
1.9%
-41.9%
Q2 24
-26.9%
-332.7%
EPS (diluted)
NUS
NUS
TEM
TEM
Q1 26
$0.04
Q4 25
$0.27
$-0.30
Q3 25
$0.34
$-0.46
Q2 25
$0.43
$-0.25
Q1 25
$2.14
$-0.40
Q4 24
$-0.73
$2.56
Q3 24
$0.17
$-0.46
Q2 24
$-2.38
$-6.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUS
NUS
TEM
TEM
Cash + ST InvestmentsLiquidity on hand
$198.7M
$604.8M
Total DebtLower is stronger
$223.6M
Stockholders' EquityBook value
$794.1M
$491.3M
Total Assets
$1.4B
$2.3B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUS
NUS
TEM
TEM
Q1 26
$198.7M
Q4 25
$239.8M
$604.8M
Q3 25
$253.0M
$655.9M
Q2 25
$265.4M
$186.3M
Q1 25
$213.6M
$151.6M
Q4 24
$198.0M
$341.0M
Q3 24
$237.8M
$388.0M
Q2 24
$232.9M
$478.8M
Total Debt
NUS
NUS
TEM
TEM
Q1 26
$223.6M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
NUS
NUS
TEM
TEM
Q1 26
$794.1M
Q4 25
$805.2M
$491.3M
Q3 25
$799.8M
$507.8M
Q2 25
$787.8M
$309.6M
Q1 25
$754.0M
$326.2M
Q4 24
$651.5M
$56.3M
Q3 24
$706.9M
$53.7M
Q2 24
$686.2M
$98.3M
Total Assets
NUS
NUS
TEM
TEM
Q1 26
$1.4B
Q4 25
$1.4B
$2.3B
Q3 25
$1.4B
$2.3B
Q2 25
$1.4B
$1.6B
Q1 25
$1.4B
$1.5B
Q4 24
$1.5B
$926.1M
Q3 24
$1.6B
$971.7M
Q2 24
$1.6B
$864.6M
Debt / Equity
NUS
NUS
TEM
TEM
Q1 26
0.28×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUS
NUS
TEM
TEM
Operating Cash FlowLast quarter
$-36.8M
Free Cash FlowOCF − Capex
$-41.5M
FCF MarginFCF / Revenue
-11.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-239.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUS
NUS
TEM
TEM
Q1 26
Q4 25
$16.6M
$-36.8M
Q3 25
$27.5M
$-119.8M
Q2 25
$35.8M
$44.2M
Q1 25
$389.0K
$-105.6M
Q4 24
$25.8M
Q3 24
$31.4M
$48.7M
Q2 24
$51.2M
$-97.1M
Free Cash Flow
NUS
NUS
TEM
TEM
Q1 26
Q4 25
$5.9M
$-41.5M
Q3 25
$17.6M
$-126.5M
Q2 25
$35.8M
$36.6M
Q1 25
$-13.2M
$-107.7M
Q4 24
$13.2M
Q3 24
$22.8M
$48.6M
Q2 24
$43.1M
$-105.1M
FCF Margin
NUS
NUS
TEM
TEM
Q1 26
Q4 25
1.6%
-11.3%
Q3 25
4.8%
-37.9%
Q2 25
9.3%
11.6%
Q1 25
-3.6%
-42.1%
Q4 24
3.0%
Q3 24
5.3%
26.9%
Q2 24
9.8%
-63.3%
Capex Intensity
NUS
NUS
TEM
TEM
Q1 26
Q4 25
2.9%
1.3%
Q3 25
2.7%
2.0%
Q2 25
0.0%
2.4%
Q1 25
3.7%
0.8%
Q4 24
2.8%
Q3 24
2.0%
0.0%
Q2 24
1.9%
4.8%
Cash Conversion
NUS
NUS
TEM
TEM
Q1 26
Q4 25
1.15×
Q3 25
1.61×
Q2 25
1.69×
Q1 25
0.00×
Q4 24
Q3 24
3.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons